1. Home
  2. ULY vs ARTL Comparison

ULY vs ARTL Comparison

Compare ULY & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ULY
  • ARTL
  • Stock Information
  • Founded
  • ULY 2013
  • ARTL 2011
  • Country
  • ULY United States
  • ARTL United States
  • Employees
  • ULY N/A
  • ARTL N/A
  • Industry
  • ULY
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ULY
  • ARTL Health Care
  • Exchange
  • ULY Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • ULY 6.3M
  • ARTL 7.0M
  • IPO Year
  • ULY N/A
  • ARTL N/A
  • Fundamental
  • Price
  • ULY $3.78
  • ARTL $5.60
  • Analyst Decision
  • ULY Strong Buy
  • ARTL Buy
  • Analyst Count
  • ULY 2
  • ARTL 2
  • Target Price
  • ULY $11.50
  • ARTL $30.00
  • AVG Volume (30 Days)
  • ULY 90.4K
  • ARTL 129.8K
  • Earning Date
  • ULY 11-11-2025
  • ARTL 11-11-2025
  • Dividend Yield
  • ULY N/A
  • ARTL N/A
  • EPS Growth
  • ULY N/A
  • ARTL N/A
  • EPS
  • ULY N/A
  • ARTL N/A
  • Revenue
  • ULY $131,235,000.00
  • ARTL N/A
  • Revenue This Year
  • ULY N/A
  • ARTL N/A
  • Revenue Next Year
  • ULY $20.23
  • ARTL N/A
  • P/E Ratio
  • ULY N/A
  • ARTL N/A
  • Revenue Growth
  • ULY N/A
  • ARTL N/A
  • 52 Week Low
  • ULY $2.99
  • ARTL $4.20
  • 52 Week High
  • ULY $17.99
  • ARTL $28.60
  • Technical
  • Relative Strength Index (RSI)
  • ULY 35.41
  • ARTL 37.32
  • Support Level
  • ULY $3.70
  • ARTL $4.60
  • Resistance Level
  • ULY $4.29
  • ARTL $5.53
  • Average True Range (ATR)
  • ULY 0.40
  • ARTL 0.58
  • MACD
  • ULY 0.04
  • ARTL 0.04
  • Stochastic Oscillator
  • ULY 9.80
  • ARTL 26.93

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: